Morepen Laboratories gets board nod to raise up to Rs 350 cr

The company's board has approved to raise funds by way of issuance of equity shares, convertible preference shares or debentures or other means through one or more qualified institutions placement for an aggregate amount not exceeding Rs 350 crore, the drug firm said in a regulatory filing.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/yit9jVG
via